Potential of antibody–drug conjugates (ADCs) for cancer therapy

The primary purpose of ADCs is to increase the efficacy of anticancer medications by minimizing systemic drug distribution and targeting specific cells. Antibody conjugates (ADCs) have changed the way cancer is treated. However, because only a tiny fraction of patients experienced long-term advantag...

Descripción completa

Detalles Bibliográficos
Autores principales: Marei, Hany E., Cenciarelli, Carlo, Hasan, Anwarul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375290/
https://www.ncbi.nlm.nih.gov/pubmed/35964048
http://dx.doi.org/10.1186/s12935-022-02679-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375290/
https://www.ncbi.nlm.nih.gov/pubmed/35964048
http://dx.doi.org/10.1186/s12935-022-02679-8

Ejemplares similares